Oxford University Innovation Granted US Patent for Viral Particle Labelling Method
Summary
Oxford University Innovation Limited has been granted US Patent 12607635B2 for a method of labelling viral particles comprising anionic lipids with fluorescently-labelled negatively-charged polynucleotides in the presence of polyvalent cations. The patent, filed on October 30, 2019, lists inventors Nicole Robb, Achillefs Kapanidis, and Jonathan Taylor, and contains 17 claims. The invention extends to methods of optically tracking particles, isolating enveloped viral particles from a sample, quantifying enveloped virus particles, and assessing enveloped viral aggregation.
“Provided herein is a method of functionalizing a particle, as well as methods of optically tracking a particle, isolating enveloped viral particles from a sample, quantifying enveloped virus particles in a sample and assessing enveloped viral aggregation in a sample.”
About this source
GovPing monitors USPTO Patent Grants - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 16 changes logged to date.
What changed
Oxford University Innovation Limited received US Patent 12607635B2 for a method of functionalizing and labelling viral particles. The method involves anionic lipids and fluorescently-labelled negatively-charged polynucleotides in the presence of polyvalent cations. The patent covers applications including optical tracking of particles, isolation of enveloped viral particles from a sample, quantification of enveloped virus particles, assessment of viral aggregation, and related kits.
Affected parties include biotechnology and life sciences firms developing viral labelling, tracking, or diagnostic tools. The patent grants Oxford University Innovation Limited enforceable exclusivity over the claimed methods, which may require licensing consideration for any parties operating in this technical space.
Scheduled event
- Date
- 2026-04-21
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Method of labelling viral particles comprising anionic lipids with fluorescently-labelled negatively-charged polynucleotides in the presence of polyvalent cations
Grant US12607635B2 Kind: B2 Apr 21, 2026
Assignee
OXFORD UNIVERSITY INNOVATION LIMITED
Inventors
Nicole Robb, Achillefs Kapanidis, Jonathan Taylor
Abstract
Provided herein is a method of functionalizing a particle, as well as methods of optically tracking a particle, isolating enveloped viral particles from a sample, quantifying enveloped virus particles in a sample and assessing enveloped viral aggregation in a sample. Kits are also provided. The particle is typically a viral particle.
CPC Classifications
C12Q 1/68 C12Q 2525/00 C12Q 2563/107 G01N 33/582 G01N 33/586 G01N 33/569 C12N 15/00 C12N 2310/3517 C12N 2405/00
Filing Date
2019-10-30
Application No.
17289900
Claims
17
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Grants - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.